A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03641300` - Efficacy of Convulsive Therapies for Bipolar Depression	N/A
Withdrawn	`NCT01495156` - Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania	Phase 4
Completed	`NCT00982020` - Study in Adolescents With Schizophrenia or Bipolar Disorder	Phase 4
Completed	`NCT00746343` - Reducing Medical Risks in Individuals With Bipolar Disorder - Full Study	N/A
Completed	`NCT00177463` - L-Carnosine for Bipolar I Disorder	N/A
Completed	`NCT03257865` - A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder	Phase 3
Completed	`NCT03259555` - A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder	Phase 3
Not yet recruiting	`NCT06433635` - Sequential Multiple Assignment Randomized Trial for Bipolar Depression	Phase 4
Completed	`NCT04127058` - Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia	Phase 1
Recruiting	`NCT05977023` - NMDA Receptor Modulation for the Treatment of Bipolar I Disorder	Phase 2
Recruiting	`NCT05340686` - Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression	N/A
Completed	`NCT03287869` - A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.	Phase 3
Enrolling by invitation	`NCT04987229` - Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects	Phase 3
Completed	`NCT00761761` - Sensoril(Ashwaganhda)for Bipolar Disorder	Phase 3
Completed	`NCT00232414` - A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder	Phase 3
Completed	`NCT03292848` - Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders	Phase 1
Active, not recruiting	`NCT04561622` - Emotional Proactive Processing in Bipolar Disorder
Recruiting	`NCT03943537` - Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders	Phase 2
Completed	`NCT03334721` - Gabapentin for Bipolar & Cannabis Use Disorders	Phase 2
Active, not recruiting	`NCT05658510` - Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)	Phase 3

NCT number	NCT01986114
Study type	Interventional
Source	Sumitomo Pharma Co., Ltd.
Contact
Status	Completed
Phase	Phase 3
Start date	January 29, 2014
Completion date	February 17, 2018

A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms